• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TACC3 是肾透明细胞癌的预后生物标志物,与免疫细胞浸润和 T 细胞耗竭相关。

TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.

机构信息

Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China.

Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou, Zhejiang, P.R. China.

出版信息

Aging (Albany NY). 2021 Mar 10;13(6):8541-8562. doi: 10.18632/aging.202668.

DOI:10.18632/aging.202668
PMID:33714201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8034911/
Abstract

Growing evidence has demonstrated that transforming acidic coiled-coil protein 3 (TACC3), a member of the TACC family, may be involved in regulating cell mitosis, transcription, and tumorigenesis. However, the role of TACC3 in kidney renal clear cell carcinoma (KIRC) remains unknown. In this study, multiple databases were used to determine the pattern of TACC3 in KIRC. We found that high TACC3 expression was associated with poor overall survival (OS) in stage I, II, IV and grade 3 KIRC patients. Univariate and multivariate Cox regression analyses showed that TACC3 was an independent risk factor for OS among KIRC patients. Moreover, TACC3 expression correlated with immune cell infiltration levels of B cells, T cells (CD8+, CD4+, follicular helper, regulatory and gamma delta), total and resting natural killer cells, total and activated dendritic cells, and resting mast cells. Furthermore, T cell exhaustion markers, such as PD1, CTLA4, LAG3 and TIM-3 were highly expressed in TACC3 overexpressing tissues. In addition, GSEA analysis revealed that the role of TACC3 in KIRC may be closely linked to immune-associated pathways. Therefore, our study reveals that TACC3 is a prognostic biomarker for OS among KIRC patients and may be associated with immune cell infiltration and T cell exhaustion.

摘要

越来越多的证据表明,转化酸性卷曲螺旋蛋白 3(TACC3)作为 TACC 家族的一员,可能参与调节细胞有丝分裂、转录和肿瘤发生。然而,TACC3 在肾透明细胞癌(KIRC)中的作用尚不清楚。在这项研究中,我们使用多个数据库来确定 TACC3 在 KIRC 中的表达模式。我们发现,TACC3 高表达与 I 期、II 期、IV 期和 3 级 KIRC 患者的总生存期(OS)不良相关。单因素和多因素 Cox 回归分析表明,TACC3 是 KIRC 患者 OS 的独立危险因素。此外,TACC3 表达与 B 细胞、T 细胞(CD8+、CD4+、滤泡辅助、调节和γδ)、总自然杀伤细胞和静息自然杀伤细胞、总树突状细胞和静息肥大细胞的免疫细胞浸润水平相关。此外,TACC3 过表达组织中高度表达了 T 细胞耗竭标志物,如 PD1、CTLA4、LAG3 和 TIM-3。此外,GSEA 分析表明,TACC3 在 KIRC 中的作用可能与免疫相关途径密切相关。因此,我们的研究表明,TACC3 是 KIRC 患者 OS 的预后生物标志物,可能与免疫细胞浸润和 T 细胞耗竭有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/74481b7dccf4/aging-13-202668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/5e76b6440def/aging-13-202668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/642d30888970/aging-13-202668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/6c6665d755fd/aging-13-202668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/0207e6af9424/aging-13-202668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/9db87158ac29/aging-13-202668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/b6902516e318/aging-13-202668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/28dc664682f8/aging-13-202668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/7818dedfe1a7/aging-13-202668-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/74481b7dccf4/aging-13-202668-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/5e76b6440def/aging-13-202668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/642d30888970/aging-13-202668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/6c6665d755fd/aging-13-202668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/0207e6af9424/aging-13-202668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/9db87158ac29/aging-13-202668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/b6902516e318/aging-13-202668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/28dc664682f8/aging-13-202668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/7818dedfe1a7/aging-13-202668-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aecb/8034911/74481b7dccf4/aging-13-202668-g009.jpg

相似文献

1
TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.TACC3 是肾透明细胞癌的预后生物标志物,与免疫细胞浸润和 T 细胞耗竭相关。
Aging (Albany NY). 2021 Mar 10;13(6):8541-8562. doi: 10.18632/aging.202668.
2
Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma.MITD1 及其相关因素对肾透明细胞癌免疫浸润的预后影响。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211036233. doi: 10.1177/15330338211036233.
3
GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.GRAMD1A 是肾透明细胞癌的生物标志物,与肿瘤微环境中的免疫浸润有关。
Dis Markers. 2022 Jul 11;2022:5939021. doi: 10.1155/2022/5939021. eCollection 2022.
4
CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.CYP2J2 是与肾透明细胞癌免疫浸润相关的诊断和预后生物标志物。
Biomed Res Int. 2021 Jun 23;2021:3771866. doi: 10.1155/2021/3771866. eCollection 2021.
5
The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.CCL5 对肾透明细胞癌患者免疫细胞浸润和预后的影响。
Int J Med Sci. 2020 Oct 18;17(18):2917-2925. doi: 10.7150/ijms.51126. eCollection 2020.
6
Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.预后生物标志物NEIL3及其与肾透明细胞癌免疫浸润的关系。
Front Oncol. 2023 Feb 2;13:1073941. doi: 10.3389/fonc.2023.1073941. eCollection 2023.
7
DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.DAB2IP 在肾细胞癌中具有重要的临床意义,并与免疫浸润相关。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820936682. doi: 10.1177/1533033820936682.
8
ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.ZEB 家族是肾透明细胞癌的预后生物标志物,与失巢凋亡和免疫浸润相关。
BMC Med Genomics. 2024 Jun 5;17(1):153. doi: 10.1186/s12920-024-01895-7.
9
Unravelling infiltrating T-cell heterogeneity in kidney renal clear cell carcinoma: Integrative single-cell and spatial transcriptomic profiling.解析肾透明细胞癌浸润性 T 细胞异质性:整合单细胞和空间转录组分析。
J Cell Mol Med. 2024 Jun;28(12):e18403. doi: 10.1111/jcmm.18403.
10
Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.单细胞和批量 RNA 测序显示,CDC45 高表达预示肾透明细胞癌患者总体生存率较差和免疫反应更差。
Biochem Genet. 2024 Jun;62(3):1502-1520. doi: 10.1007/s10528-023-10500-y. Epub 2023 Aug 29.

引用本文的文献

1
Subtype-WGME enables whole-genome-wide multi-omics cancer subtyping.亚型-WGME 可实现全基因组多组学癌症亚型划分。
Cell Rep Methods. 2024 Jun 17;4(6):100781. doi: 10.1016/j.crmeth.2024.100781. Epub 2024 May 17.
2
promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating expression.通过调节表达促进肝癌细胞的增殖、迁移和侵袭。
Biomol Biomed. 2024 Sep 6;24(5):1216-1230. doi: 10.17305/bb.2024.10247.
3
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

本文引用的文献

1
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.肿瘤内龛位维持并分化具有干细胞样特征的 CD8+T 细胞。
Nature. 2019 Dec;576(7787):465-470. doi: 10.1038/s41586-019-1836-5. Epub 2019 Dec 11.
2
TCR Repertoire Diversity of Peripheral PD-1CD8 T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer.外周 PD-1CD8 T 细胞 TCR repertoire 多样性预测非小细胞肺癌患者免疫治疗后的临床结局。
Cancer Immunol Res. 2020 Jan;8(1):146-154. doi: 10.1158/2326-6066.CIR-19-0398. Epub 2019 Nov 12.
3
Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy.
靶向 TACC3 诱导免疫原性细胞死亡并增强曲妥珠单抗-美坦新偶联物在 HER2 阳性乳腺癌中的反应。
Cancer Res. 2024 May 2;84(9):1475-1490. doi: 10.1158/0008-5472.CAN-23-2812.
4
Identification of molecular characteristics of FUT8 and alteration of core fucosylation in kidney renal clear cell cancer.鉴定肾透明细胞癌 FUT8 的分子特征及核心岩藻糖基化的改变。
Aging (Albany NY). 2024 Jan 25;16(3):2299-2319. doi: 10.18632/aging.205482.
5
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness.TACC3:一种具有多功能的蛋白,促进癌细胞的存活和侵袭能力。
Cell Cycle. 2023 Dec-Dec;22(23-24):2637-2655. doi: 10.1080/15384101.2024.2302243. Epub 2024 Jan 10.
6
Two novel predictive biomarkers for osteosarcoma and glycolysis pathways: A profiling study on HS2ST1 and SDC3.两个用于骨肉瘤和糖酵解途径的新型预测生物标志物:HS2ST1 和 SDC3 的分析研究。
Medicine (Baltimore). 2022 Sep 9;101(36):e30192. doi: 10.1097/MD.0000000000030192.
7
High Expression of Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients.高表达与肺腺癌患者的不良预后和免疫浸润有关。
Dis Markers. 2022 Jul 9;2022:8789515. doi: 10.1155/2022/8789515. eCollection 2022.
8
TLN2 functions as a tumor suppressor in clear cell renal cell carcinoma via inactivation of the Wnt/β-catenin signaling pathway.TLN2通过使Wnt/β-连环蛋白信号通路失活,在透明细胞肾细胞癌中发挥肿瘤抑制作用。
Transl Androl Urol. 2022 Jan;11(1):39-52. doi: 10.21037/tau-21-914.
9
Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma.综合分析揭示肺腺癌细胞衰老的预后和免疫原性特征。
Front Cell Dev Biol. 2021 Nov 16;9:780461. doi: 10.3389/fcell.2021.780461. eCollection 2021.
10
A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.基于缺氧基因子集的新型放射基因组学生物标志物:肾透明细胞癌的准确生存及预后预测
Front Oncol. 2021 Oct 7;11:739815. doi: 10.3389/fonc.2021.739815. eCollection 2021.
肾细胞癌靶向治疗的细胞死亡相关分子和生物标志物
Cancer Cell Int. 2019 Aug 23;19:221. doi: 10.1186/s12935-019-0939-2. eCollection 2019.
4
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.LAYN 是胃癌和结肠癌的预后生物标志物,并与免疫浸润相关。
Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
5
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.纳武利尤单抗联合伊匹单抗对比舒尼替尼治疗晚期肾细胞癌患者的患者报告结局(CheckMate 214):一项随机、III 期试验。
Lancet Oncol. 2019 Feb;20(2):297-310. doi: 10.1016/S1470-2045(18)30778-2. Epub 2019 Jan 15.
6
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.单细胞分析乳腺癌 T 细胞揭示了与改善预后相关的组织驻留记忆亚群。
Nat Med. 2018 Jul;24(7):986-993. doi: 10.1038/s41591-018-0078-7. Epub 2018 Jun 25.
7
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.使用独立数据集的表达数据验证 miRNA 在肝细胞癌中的预后能力。
Sci Rep. 2018 Jun 15;8(1):9227. doi: 10.1038/s41598-018-27521-y.
8
High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.TACC2 在肝癌中的高表达与不良预后相关。
Cancer Biomark. 2018;22(4):611-619. doi: 10.3233/CBM-170091.
9
Downregulation of TACC3 inhibits tumor growth and migration in osteosarcoma cells through regulation of the NF-κB signaling pathway.TACC3的下调通过调节NF-κB信号通路抑制骨肉瘤细胞的肿瘤生长和迁移。
Oncol Lett. 2018 May;15(5):6881-6886. doi: 10.3892/ol.2018.8262. Epub 2018 Mar 14.
10
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.巨噬细胞阻碍 CD8 T 细胞到达肿瘤细胞,并限制抗 PD-1 治疗的效果。
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050. doi: 10.1073/pnas.1720948115. Epub 2018 Apr 9.